688065 凯赛生物
交易中 09-04 10:30:11
资讯
新帖
简况
凯赛生物被调出科创50指数 A股共募115亿IPO中信证券保荐
中金财经 · 09-01 11:34
凯赛生物被调出科创50指数 A股共募115亿IPO中信证券保荐
每周股票复盘：凯赛生物（688065）股东拟减持不超2%股份
证券之星 · 08-30
每周股票复盘：凯赛生物（688065）股东拟减持不超2%股份
破发股凯赛生物股东拟减持 A股募115亿IPO中信证券保荐
中金财经 · 08-25
破发股凯赛生物股东拟减持 A股募115亿IPO中信证券保荐
凯赛生物（688065）披露持股5%以上股东减持股份计划公告，8月24日股价下跌2.81%
证券之星 · 08-24
凯赛生物（688065）披露持股5%以上股东减持股份计划公告，8月24日股价下跌2.81%
凯赛生物公告：股东拟于9月15日至12月14日期间减持不超2%股份
美股速递 · 08-24
凯赛生物公告：股东拟于9月15日至12月14日期间减持不超2%股份
每周股票复盘：凯赛生物（688065）Q2净利增20.56%
证券之星 · 08-23
每周股票复盘：凯赛生物（688065）Q2净利增20.56%
股市必读：凯赛生物中报 - 第二季度单季净利润同比增长20.56%
证券之星 · 08-21
股市必读：凯赛生物中报 - 第二季度单季净利润同比增长20.56%
凯赛生物（688065）披露2026年半年度报告，8月19日股价下跌1.34%
证券之星 · 08-19
凯赛生物（688065）披露2026年半年度报告，8月19日股价下跌1.34%
凯赛生物最新公告：2026年半年度净利润同比增长20.75%
证券之星 · 08-19
凯赛生物最新公告：2026年半年度净利润同比增长20.75%
每周股票复盘：凯赛生物（688065）将召开2026年半年度业绩说明会
证券之星 · 08-16
每周股票复盘：凯赛生物（688065）将召开2026年半年度业绩说明会
凯赛生物（688065）披露2026年半年度业绩说明会召开安排，8月13日股价下跌1.15%
证券之星 · 08-13
凯赛生物（688065）披露2026年半年度业绩说明会召开安排，8月13日股价下跌1.15%
破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐
中金财经 · 08-12
破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐
凯赛生物：复材无人车地板、蒙皮等产品已批量交付
证券之星 · 08-07
凯赛生物：复材无人车地板、蒙皮等产品已批量交付
凯赛生物：公司正同招商局体系内多家成员单位针对生物基聚酰胺复合材料的场景应用进行项目合作
证券之星 · 08-07
凯赛生物：公司正同招商局体系内多家成员单位针对生物基聚酰胺复合材料的场景应用进行项目合作
每周股票复盘：凯赛生物（688065）每10股派4.50元
证券之星 · 07-26
每周股票复盘：凯赛生物（688065）每10股派4.50元
凯赛生物（688065）披露2025年年度权益分派实施公告，7月22日股价下跌2.14%
证券之星 · 07-22
凯赛生物（688065）披露2025年年度权益分派实施公告，7月22日股价下跌2.14%
凯赛生物：2025年度实施差异化分红 拟派现3.24亿元
格隆汇 · 07-22
凯赛生物：2025年度实施差异化分红 拟派现3.24亿元
7月20日凯赛生物涨8.28%，科创新材料ETF博时基金重仓该股
证券之星 · 07-20
7月20日凯赛生物涨8.28%，科创新材料ETF博时基金重仓该股
每周股票复盘：凯赛生物（688065）起诉十被告索赔约9.67亿元
证券之星 · 07-19
每周股票复盘：凯赛生物（688065）起诉十被告索赔约9.67亿元
凯赛生物获得发明专利授权：“连续纤维增强生物基共聚酰胺管材及其制备方法和应用”
证券之星 · 07-15
凯赛生物获得发明专利授权：“连续纤维增强生物基共聚酰胺管材及其制备方法和应用”
加载更多
公司概况
公司名称：
上海凯赛生物技术股份有限公司
所属行业：
化学纤维制造业
上市日期：
2020-08-12
主营业务：
上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC9-DC18）及其衍生产品、生物基戊二胺、系列生物基聚酰胺树脂及其改性产品、生物基连续纤维热塑型复合材料（Bio-PPACFRT）、生物基哌啶。
发行价格：
133.45
{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":42.44,"timestamp":1788489011000,"preClose":42.42,"halted":0,"volume":1299005,"delay":0,"changeRate":0.0005,"floatShares":583000000,"shares":721000000,"eps":0.8663,"marketStatus":"交易中","change":0.02,"latestTime":"09-04 10:30:11","open":42.6,"high":42.89,"low":42.4,"amount":55364200,"amplitude":0.0116,"askPrice":42.49,"askSize":8,"bidPrice":42.43,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.8663,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1788492600000},"marketStatusCode":2,"adr":0,"adjPreClose":42.42,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":46.66,"lowLimit":38.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":721289794,"isCdr":false,"pbRate":1.72,"roa":"--","peRate":48.989957,"roe":"2.08%","epsLYR":0.82,"committee":0.436242,"marketValue":30612000000,"turnoverRate":0.0022,"status":0,"floatMarketCap":24759000000},"requestUrl":"/m/hq/s/688065","defaultTab":"news","newsList":[{"id":"2664880314","title":"凯赛生物被调出科创50指数 A股共募115亿IPO中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880314","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664880314?lang=zh_cn&edition=full","pubTime":"2026-09-01 11:34","pubTimestamp":1788233643,"startTime":"0","endTime":"0","summary":"中国经济网北京9月1日讯 上海证券交易所与中证指数有限公司披露将调整科创50等指数样本，于2026年9月11日收市后生效，其中科创50指数更换5只样本，凯赛生物 被调出。 凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。 凯赛生物上述2次募集资金合计114.87亿元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/01/20260901607569.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/01/20260901607569.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260901/32356125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159371","LU0405327148.USD","LU1781817850.SGD","IPOS","LU2289578879.USD","LU2580892789.USD","BK1521","LU1064130708.USD","LU1997245094.SGD","BK0028","LU0405327494.USD","83130","KCE","02846","LU2148510915.USD","BK0188","159982","REDS","LU1255011170.USD","LU1794554557.SGD","LU2580892862.HKD","83188","BK4127","BK1564","688065","03188","BK0276","02827","LU1146622755.USD","LU1820825898.SGD","LU2495084118.USD","LU1997245177.USD","LU1997244956.HKD","07233","BK0183","FRHC","LU1328615791.USD","LU1655091616.SGD","BK1516","BK0196","06030","LU1580142542.USD","LU1720050803.USD","BK0012","LU1064131003.USD","399300","BK0208","03130","82846","600030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043339","title":"每周股票复盘：凯赛生物（688065）股东拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043339","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663043339?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:47","pubTimestamp":1788043629,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，凯赛生物报收于43.16元，较上周的45.27元下跌4.66%。本周，凯赛生物8月24日盘中最高价报45.4元。本周关注点公司公告汇总：持股5.57%股东计划减持不超过总股本2%的股份公司公告汇总关于持股5%以上股东减持股份计划的公告截至公告披露日，山西科技创新城投资开发有限公司持有上海凯赛生物技术股份有限公司40,139,958股，占总股本的5.57%，股份来源于IPO前及资本公积转增。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788498","title":"破发股凯赛生物股东拟减持 A股募115亿IPO中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788498","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662788498?lang=zh_cn&edition=full","pubTime":"2026-08-25 11:07","pubTimestamp":1787627233,"startTime":"0","endTime":"0","summary":"中国经济网北京8月25日讯 凯赛生物 昨日晚间披露《关于持股5%以上股东减持股份计划的公告》。山西科创城投减持计划拟自公告披露之日起15个交易日后的3个月内进行，减持价格将参考市场价格。 截至公告披露之日，山西科创城投持有凯赛生物40,139,958股股份，占凯赛生物总股本的5.57%。 截至2026年6月30日，山西科创城投为凯赛生物第四大股东。 凯赛生物上述2次募集资金合计114.87亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260825/32345897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02846","83188","159982","688065","600030","BK0183","REDS","KCE","LU1655091616.SGD","LU1064131003.USD","LU2580892862.HKD","FRHC","BK0188","LU1720050803.USD","LU1794554557.SGD","07233","82846","83130","02827","03130","LU1997245177.USD","BK1564","IPOS","LU2495084118.USD","LU1997244956.HKD","BK1516","LU2148510915.USD","399300","BK0012","BK0028","03188","LU1064130708.USD","LU0405327494.USD","06030","LU1781817850.SGD","BK1521","LU0405327148.USD","LU2580892789.USD","LU1580142542.USD","BK0196","LU1255011170.USD","BK4127","LU1328615791.USD","LU2289578879.USD","BK0276","BK0208","LU1997245094.SGD","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661827441","title":"凯赛生物（688065）披露持股5%以上股东减持股份计划公告，8月24日股价下跌2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661827441","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661827441?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:08","pubTimestamp":1787580481,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，凯赛生物报收于44.0元，较前一交易日下跌2.81%，最新总市值为317.37亿元。该股当日开盘45.18元，最高45.4元，最低43.56元，成交额达2.43亿元，换手率为0.94%。近日，凯赛生物发布《关于持股5%以上股东减持股份计划的公告》。减持价格将参考市场价格，减持期间为2026年9月15日至2026年12月14日。本次减持计划符合相关法律法规规定，实施存在不确定性，不会导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400036807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174533391","title":"凯赛生物公告：股东拟于9月15日至12月14日期间减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1174533391","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174533391?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:27","pubTimestamp":1787567229,"startTime":"0","endTime":"0","summary":"凯赛生物披露，其股东已明确表态，计划在9月15日至12月14日这一时间窗口内，对公司股份进行减持操作。据悉，此番减持规模上限为公司总股本的2%。此举无疑引发市场关注，投资者对此举背后的动因及潜在影响议论纷纷。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661521124","title":"每周股票复盘：凯赛生物（688065）Q2净利增20.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661521124","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661521124?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:32","pubTimestamp":1787423531,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，凯赛生物报收于45.27元，较上周的46.6元下跌2.85%。本周，凯赛生物8月20日盘中最高价报48.16元。本周关注点来自业绩披露要点：2026年第二季度归母净利润2.07亿元，同比上升20.56%。《2026年度提质增效重回报专项行动方案》半年度评估报告显示，公司实现营收190,018万元，同比增长13.73%；归母净利润37,273万元，同比增长20.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661231257","title":"股市必读：凯赛生物中报 - 第二季度单季净利润同比增长20.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661231257","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661231257?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:56","pubTimestamp":1787252171,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，凯赛生物报收于46.29元，上涨0.09%，换手率1.05%，成交量6.14万手，成交额2.89亿元。业绩披露要点：2026年上半年主营收入19.0亿元，归母净利润3.73亿元，第二季度单季归母净利润2.07亿元。公司公告汇总：董事会审议通过作废2022年限制性股票激励计划中74.123万股已授予尚未归属的限制性股票，并确认2019年及2023年两期募集资金均已使用完毕、专户注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100002092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429532","title":"凯赛生物（688065）披露2026年半年度报告，8月19日股价下跌1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429532","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429532?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:13","pubTimestamp":1787148796,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，凯赛生物报收于46.25元，较前一交易日下跌1.34%，最新总市值为333.6亿元。该股当日开盘46.8元，最高47.0元，最低45.62元，成交额达2.41亿元，换手率为0.9%。近日，凯赛生物披露《2026年半年度报告》。本报告期实现营业收入1,900,180,844.78元，同比增长13.73%；利润总额为426,995,105.29元，同比增长24.81%；归属于上市公司股东的净利润为372,730,644.26元，同比增长20.75%。经营活动产生的现金流量净额为750,599,232.82元，同比增长121.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900043036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440659","title":"凯赛生物最新公告：2026年半年度净利润同比增长20.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440659","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660440659?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:31","pubTimestamp":1787139068,"startTime":"0","endTime":"0","summary":"凯赛生物(688065.SH)公告称，公司发布2026年半年度报告，实现营业收入19亿元，同比增长13.73%；归属于上市公司股东的净利润3.73亿元，同比增长20.75%。注：公司Q2净利润2.07亿，Q1净利润1.66亿，据此计算，Q2净利润环比增长24%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900037047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659766621","title":"每周股票复盘：凯赛生物（688065）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2659766621","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659766621?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:01","pubTimestamp":1786820475,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，凯赛生物报收于46.6元，较上周的48.95元下跌4.8%。本周，凯赛生物8月11日盘中最高价报49.79元。本周关注点公司公告汇总：凯赛生物将于2026年08月21日召开2026年半年度业绩说明会。公司公告汇总关于召开2026年半年度业绩说明会的公告上海凯赛生物技术股份有限公司将于2026年08月21日14:00-15:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司2026年半年度经营成果及财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716894","title":"凯赛生物（688065）披露2026年半年度业绩说明会召开安排，8月13日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716894","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659716894?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:13","pubTimestamp":1786630398,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，凯赛生物报收于46.61元，较前一交易日下跌1.15%，最新总市值为336.19亿元。近日，凯赛生物发布《关于召开2026年半年度业绩说明会的公告》。公告显示，公司将于2026年08月21日14:00-15:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司2026年半年度经营成果及财务状况。投资者可于2026年08月14日至08月20日16:00前登录上证路演中心提问预征集栏目提交问题。说明会召开后可通过上证路演中心查看会议情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300039581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658276829","title":"破发股凯赛生物跌3.32% A股共募115亿IPO中信证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2658276829","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658276829?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:55","pubTimestamp":1786521304,"startTime":"0","endTime":"0","summary":"中国经济网北京8月12日讯 凯赛生物 今日收报47.15元，跌幅3.32%。该股目前处于破发状态。 凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。 凯赛生物于2025年3月28日披露《向特定对象发行A股股票发行情况报告书》。 凯赛生物上述2次募集资金合计114.87亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260812/32332749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["399300","LU1720050803.USD","BK1521","BK0188","BK4127","BK1147","BK0183","LU0405327148.USD","LU2580892789.USD","688065","BK1516","LU1794554557.SGD","LU2148510915.USD","LU1064130708.USD","LU1580142542.USD","159982","LU1997244956.HKD","LU2580892862.HKD","BK0196","BK0208","BK1564","KCE","LU1997245177.USD","LU2495084118.USD","LU1655091616.SGD","LU1328615791.USD","IPOS","LU1255011170.USD","600030","LU0405327494.USD","BK0276","BK0012","FRHC","06030","LU1064131003.USD","LU2289578879.USD","LU1781817850.SGD","BK0028","REDS","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657761894","title":"凯赛生物：复材无人车地板、蒙皮等产品已批量交付","url":"https://stock-news.laohu8.com/highlight/detail?id=2657761894","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657761894?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:33","pubTimestamp":1786088005,"startTime":"0","endTime":"0","summary":"证券之星消息，凯赛生物08月07日在投资者关系平台上答复投资者关心的问题。目前，公司的复材无人车地板、蒙皮、航空集装箱、储能箱板等产品都已经在客户层面实现批量交付；动力电池上盖产品在进行产品试制和客户测试认证；光伏边框、建筑模版、门窗、纤维筋等产品在进行工艺、产品开发并联合下游合作方推进示范、试点项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700021080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657618962","title":"凯赛生物：公司正同招商局体系内多家成员单位针对生物基聚酰胺复合材料的场景应用进行项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2657618962","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657618962?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:33","pubTimestamp":1786087997,"startTime":"0","endTime":"0","summary":"证券之星消息，凯赛生物08月07日在投资者关系平台上答复投资者关心的问题。之前，招商公众号中只要一提到绿色科技，必会提到凯赛的复材相关产品为举例，但这次没有，却提到了二氧化碳转化路线，请问公司对这个是怎么理解的？公司与招商局集团的业务合作正在稳步推进中。公司正同招商局体系内多家成员单位针对生物基聚酰胺复合材料的场景应用进行项目合作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700021073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057347","title":"每周股票复盘：凯赛生物（688065）每10股派4.50元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057347","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057347?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:20","pubTimestamp":1785003622,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，凯赛生物报收于43.19元，较上周的42.75元上涨1.03%。本周，凯赛生物7月21日盘中最高价报47.31元。本周关注点公司公告汇总：凯赛生物每10股派发现金红利4.50元（含税），股权登记日为2026年7月28日。公司公告汇总上海凯赛生物技术股份有限公司2025年年度权益分派实施公告显示，本次利润分配方案已于2026年6月25日经年度股东会审议通过。分红基数为扣除回购股份后的总股本，每10股派发现金红利4.50元（含税），合计拟派发324,040,407.30元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653668197","title":"凯赛生物（688065）披露2025年年度权益分派实施公告，7月22日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653668197","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653668197?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:19","pubTimestamp":1784729955,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，凯赛生物报收于44.82元，较前一交易日下跌2.14%，最新总市值为323.28亿元。近日，凯赛生物发布2025年年度权益分派实施公告。本次利润分配方案经2026年6月25日召开的2025年年度股东会审议通过。股权登记日为2026年7月28日，除权（息）日为2026年7月29日，现金红利发放日为2026年7月29日。截至公告日，公司总股本721,289,794股，扣除回购股份1,200,000股，拟派发现金红利总额324,040,407.30元（含税）。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653375509","title":"凯赛生物：2025年度实施差异化分红 拟派现3.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653375509","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653375509?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:32","pubTimestamp":1784712752,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652008295","title":"7月20日凯赛生物涨8.28%，科创新材料ETF博时基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652008295","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652008295?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:24","pubTimestamp":1784535867,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日凯赛生物涨8.28%，收盘报46.29元，换手率1.44%，成交量8.42万手，成交额3.72亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为博时基金的科创新材料ETF博时。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065","588010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230685","title":"每周股票复盘：凯赛生物（688065）起诉十被告索赔约9.67亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230685?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:29","pubTimestamp":1784399348,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，凯赛生物报收于42.75元，较上周的44.85元下跌4.68%。本周，凯赛生物7月13日盘中最高价报45.0元。凯赛生物当前最新总市值308.35亿元，在化学制品板块市值排名9/171，在两市A股市值排名612/5199。本周关注点公司公告汇总：凯赛生物及子公司就侵害技术秘密纠纷提起诉讼，索赔金额合计约9.67亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651865954","title":"凯赛生物获得发明专利授权：“连续纤维增强生物基共聚酰胺管材及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2651865954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651865954?lang=zh_cn&edition=full","pubTime":"2026-07-15 03:27","pubTimestamp":1784057222,"startTime":"0","endTime":"0","summary":"今年以来凯赛生物新获得专利授权35个，较去年同期增加了12.9%。通过天眼查大数据分析，上海凯赛生物技术股份有限公司共对外投资了15家企业，参与招投标项目8次；财产线索方面有商标信息158条，专利信息807条，著作权信息11条；此外企业还拥有行政许可9个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500004882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788489014831,"stockEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0746},{"period":"3month","weight":-0.0416},{"period":"6month","weight":-0.1901},{"period":"1year","weight":-0.1727},{"period":"ytd","weight":-0.1395}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0313},{"period":"3month","weight":-0.0213},{"period":"6month","weight":-0.0442},{"period":"1year","weight":0.0337},{"period":"ytd","weight":-0.0067}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","boardName":"化学纤维制造业","stockholders":"19123人(较上一季度增加3.24%)","perCapita":"30506股","listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","registeredCapital":"72128万元","survey":" 上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC9-DC18）及其衍生产品、生物基戊二胺、系列生物基聚酰胺树脂及其改性产品、生物基连续纤维热塑型复合材料（Bio-PPACFRT）、生物基哌啶。","listedPrice":133.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}